Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. | Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. But the disease can be silent, so millions of Americans—especially Black Americans—don’t know they have it until it’s too late. Johnson & Johnson’s Janssen unit is hoping to change that with a new awareness initiative.
Peripheral Artery Disease Screening in the Community and 1-Year
Activating Our Commitment to Health Equity - Johnson & Johnson We
PDF) Lower Extremity Revascularization Using Directional
Education Save Legs. Change Lives™
Revolutionary Solutions: Improving Outcomes for Peripheral Artery
Amy Carmen-Hall posted on LinkedIn
Intravascular ultrasound use in peripheral arterial and deep
The Janssen Pharmaceutical Companies of Johnson & Johnson on
Official Website Save Legs. Change Lives™
Peripheral Artery Disease
Deborah Epps, PharmD on LinkedIn: J&J aims to 'save legs, change
ESVM Guideline on peripheral arterial disease
Amy Carmen-Hall posted on LinkedIn
